PhaseBio Pharmaceuticals (PHAS) Stock Price, News & Analysis
PHAS
Published by Stock Titan
Data refreshed
What Changed
Price Move History
- Daily moves over 5%
- 97 253 sessions, November 2, 2021 to November 2, 2022
- Largest daily move
- -66.2% close of September 28, 2022
- 1-year change
- -98.3% closing prices, November 2, 2021 to November 2, 2022
- 1-month change
- -60.2% closing prices, September 30, 2022 to November 2, 2022
Company Description
PHAS has declined 98.3% over the past year. The last closing price was $0.0701.
This page collects what Stock Titan holds for PHAS, including price data and latest news.
Stock Performance
$—
-
-
Last updated:
-98.3%
Performance 1 year
PhaseBio Pharmaceuticals (PHAS) closed at $0.0701 on November 2, 2022. Over the past 12 months, the price has lost 98.3%.
PHAS Metrics & Rankings
Price returns through November 2, 2022. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
PhaseBio Pharmaceuticals has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 7 with negative movement. Key topics include earnings, fda approval, conferences, clinical trial. View all PHAS news →
SEC Filings
Frequently Asked Questions
What is the current quoted price of PhaseBio Pharmaceuticals (PHAS)?
The current quoted price of PhaseBio Pharmaceuticals (PHAS) is $0.0701 as of November 2, 2022.